Literature DB >> 23138109

Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells.

Ming-Zhen Zhang1, Rong-Na Yu, Jun Chen, Zhi-Ya Ma, Yuan-Di Zhao.   

Abstract

Quantum dots (QDs) fluorescent probes based on oligonucleotide aptamers and peptides with specific molecular recognition have attracted much attention. In this paper, CdSe/ZnS QDs probes for targeted delivery to mouse and human cells using aptamer GS24 and peptide T7 specific to mouse/human transferrin receptors were developed. Capillary electrophoresis analyses indicated that the optimal molar ratios of QDs to aptamer or peptide were 1:5. Fluorescence and confocal microscope imaging revealed QD-GS24 and QD-T7 probes were able to specifically recognize B16 cells and HeLa cells respectively. Quantitative flow cytometry analysis indicated the transportation of QD-GS24 or QD-T7 into cells could be promoted by corresponding free transferrin. Transmission electron microscopy confirmed the uptake of probes in cells and the effective intracellular delivery. MTT assay suggested the cytotoxicity of probes was related to the surface ligand, and aptamer GS24 (or peptide T7) could reduce the cytotoxicity of probes to a certain degree. The study has great significance for preparing QDs fluorescent probes using non-antibody target molecules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138109     DOI: 10.1088/0957-4484/23/48/485104

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  14 in total

Review 1.  Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.

Authors:  Anish Babu; Amanda K Templeton; Anupama Munshi; Rajagopal Ramesh
Journal:  AAPS PharmSciTech       Date:  2014-02-19       Impact factor: 3.246

Review 2.  Plant derived edible nanoparticles as a new therapeutic approach against diseases.

Authors:  Mingzhen Zhang; Emilie Viennois; Changlong Xu; Didier Merlin
Journal:  Tissue Barriers       Date:  2016-02-11

3.  Meta-analysis of cellular toxicity for cadmium-containing quantum dots.

Authors:  Eunkeu Oh; Rong Liu; Andre Nel; Kelly Boeneman Gemill; Muhammad Bilal; Yoram Cohen; Igor L Medintz
Journal:  Nat Nanotechnol       Date:  2016-02-29       Impact factor: 39.213

Review 4.  Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.

Authors:  Charalambos Kaittanis; Travis M Shaffer; Daniel L J Thorek; Jan Grimm
Journal:  Crit Rev Oncog       Date:  2014

5.  Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells.

Authors:  Hoon Young Kong; Jonghoe Byun
Journal:  Mol Cells       Date:  2015-01-15       Impact factor: 5.034

6.  Syndiotactic hexamer peptide nanodots.

Authors:  Vivek Prakash; B Mukesh; Sajitha Sasidharan; Amay Sanjay Redkar; Abhishek Roy; R Anandalakshmi; Vibin Ramakrishnan
Journal:  Eur Biophys J       Date:  2022-07-22       Impact factor: 2.095

7.  Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.

Authors:  Mingzhen Zhang; Bo Xiao; Huan Wang; Moon Kwon Han; Zhan Zhang; Emilie Viennois; Changlong Xu; Didier Merlin
Journal:  Mol Ther       Date:  2016-08-05       Impact factor: 11.454

Review 8.  Nanoparticles and radiotracers: advances toward radionanomedicine.

Authors:  Edwin C Pratt; Travis M Shaffer; Jan Grimm
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-23

Review 9.  Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.

Authors:  Haseeb Anwar Dad; Ting-Wei Gu; Ao-Qing Zhu; Lu-Qi Huang; Li-Hua Peng
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

10.  Selective Targeting to Glioma with Nucleic Acid Aptamers.

Authors:  Shraddha Aptekar; Mohit Arora; Clare Louise Lawrence; Robert William Lea; Katherine Ashton; Tim Dawson; Jane Elizabeth Alder; Lisa Shaw
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.